US03837C1062 - Common Stock
APYX MEDICAL CORP
NASDAQ:APYX (4/25/2024, 7:00:00 PM)
1.48
-0.02 (-1.33%)
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 276 full-time employees. The firm operates through two segments: Advanced Energy and OEM. Its Advanced Energy product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. These product lines consist of a multifunction generator, a handpiece, and a supply of helium gas. Its primary focus is on the cosmetic surgery market where Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. The firm designs, develops, and manufactures electrosurgical equipment by producing generators and related accessories for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies with the need for its energy-based designs. Its wholly owned subsidiary is Apyx Bulgaria, EOOD.
APYX MEDICAL CORP
5115 Ulmerton Rd
Clearwater FLORIDA 33760
P: 18005372790
CEO: Charles D. Goodwin II
Employees: 276
Website: https://apyxmedical.com/
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apyx Medical (NASDAQ:APYX) just reported results for the fourth quarter of 2023...
Here you can normally see the latest stock twits on APYX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: